Global Women’s Health Drugs Market Growth, Trends, and Forecasts 2016-2026

April 2021 | 118 pages | ID: G8525374097FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this latest study, the 2021 growth of Women’s Health Drugs will have significant change from previous year. By the most conservative estimates of global Women’s Health Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Women’s Health Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Women’s Health Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by product type

• EVISTA
• XGEVA
• Prolia
• Mirena
• Zometa
• Reclast/Aclasta
• Minastrin 24 Fe
• Others (Premarin, ACTONEL, ORTHO TRI-CY LO)

Segmentation by Application

• Hormonal Infertility
• Postmenopausal Osteoporosis
• Endometriosis
• Contraceptives
• Menopause
• Polycystic Ovary Syndrome
• Other Applications

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• Rest of Americas
• APAC
• China
• Japan
• Korea
• Taiwan
• India
• Australia
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Rest of APAC
• Europe
• Germany
• France
• UK
• Russia
• Italy
• Benelux
• Nordic
• Rest of Europe
• MENA
• Saudi Arabia
• UAE
• Turkey
• South Africa
• Egypt
• Rest of MENA

The report also presents the market competition landscape and a corresponding detailed analysis of the major companies in the market.

• Bayer AG
• Allergan
• Merck & Co
• Pfizer Inc
• Amgen
• Agile Therapeutics Inc
• Ferring Pharmaceuticals
• Mylan N.V.
• Lupin (India)
• Eli Lilly And Company
• Novartis AG
• Johnson & Johnson

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 Market Overview
  2.1.1 Global Women’s Health Drugs Market Size and Forecast, 2016-2026
  2.1.2 Women’s Health Drugs Market Size and Forecast by Region, 2016 VS 2021 VS 2026
2.2 Global Women’s Health Drugs Market Size and Forecast by Regions, 2016-2026 ($ millions)
2.3 Americas Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
2.4 APAC Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
2.5 Europe Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
2.6 MENA Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)

3 WOMEN’S HEALTH DRUGS MARKET SIZE BY PLAYER

3.1 Global Women’s Health Drugs Market Size by Player
  3.1.1 Global Top Players Women’s Health Drugs Revenue, 2019-2021E ($ millions)
  3.1.2 Global Top Women’s Health Drugs Players Market Share, 2019-2021E
3.2 Global Key Women’s Health Drugs Players Rank in 2020
3.3 Global Key Women’s Health Drugs Players Head office and Products Offered
3.4 Market Concentration Rate Analysis
  3.4.1 Competition Landscape Analysis
  3.4.2 Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
3.5 New Products and Potential Entrants
3.6 Mergers & Acquisitions, Expansion

4 WOMEN’S HEALTH DRUGS SEGMENT BY TYPE

4.1 Overview
  4.1.1 EVISTA
  4.1.2 XGEVA
  4.1.3 Prolia
  4.1.4 Mirena
  4.1.5 Zometa
  4.1.6 Reclast/Aclasta
  4.1.7 Minastrin 24 Fe
  4.1.8 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
4.2 Global Women’s Health Drugs Market Size by Type, 2016-2026 ($ millions)
4.3 EVISTA Market Size by Region, 2016-2026 ($ millions)
4.4 XGEVA Market Size by Region, 2016-2026 ($ millions)
4.5 Prolia Market Size by Region, 2016-2026 ($ millions)
4.6 Mirena Market Size by Region, 2016-2026 ($ millions)
4.7 Zometa Market Size by Region, 2016-2026 ($ millions)
4.8 Reclast/Aclasta Market Size by Region, 2016-2026 ($ millions)
4.9 Minastrin 24 Fe Market Size by Region, 2016-2026 ($ millions)
4.10 Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Market Size by Region, 2016-2026 ($ millions)

5 WOMEN’S HEALTH DRUGS SEGMENT BY APPLICATION

5.1 Overview
  5.1.1 Hormonal Infertility
  5.1.2 Postmenopausal Osteoporosis
  5.1.3 Endometriosis
  5.1.4 Contraceptives
  5.1.5 Menopause
  5.1.6 Polycystic Ovary Syndrome
  5.1.7 Other Applications
5.2 Global Women’s Health Drugs Market Size and Forecast by Application, 2016-2026
5.3 Hormonal Infertility Market Size by Region, 2016-2026 ($ millions)
5.4 Postmenopausal Osteoporosis Market Size by Region, 2016-2026 ($ millions)
5.5 Endometriosis Market Size by Region, 2016-2026 ($ millions)
5.6 Contraceptives Market Size by Region, 2016-2026 ($ millions)
5.7 Menopause Market Size by Region, 2016-2026 ($ millions)
5.8 Polycystic Ovary Syndrome Market Size by Region, 2016-2026 ($ millions)
5.9 Other Applications Market Size by Region, 2016-2026 ($ millions)

6 AMERICAS

6.1 Americas Women’s Health Drugs Market Size by Country
6.2 United States Women’s Health Drugs Market Size
6.3 Canada Women’s Health Drugs Market Size
6.4 Mexico Women’s Health Drugs Market Size
6.5 Brazil Women’s Health Drugs Market Size

7 APAC

7.1 APAC Women’s Health Drugs Market Size by Region
7.2 China Women’s Health Drugs Market Size
7.3 Japan Women’s Health Drugs Market Size
7.4 Korea Women’s Health Drugs Market Size
7.5 Taiwan Women’s Health Drugs Market Size
7.6 India Women’s Health Drugs Market Size
7.7 Australia Women’s Health Drugs Market Size
7.8 Indonesia Women’s Health Drugs Market Size
7.9 Thailand Women’s Health Drugs Market Size
7.10 Malaysia Women’s Health Drugs Market Size
7.11 Philippines Women’s Health Drugs Market Size
7.12 Vietnam Women’s Health Drugs Market Size

8 EUROPE

8.1 Europe Women’s Health Drugs Market Size by Country
8.2 Germany Women’s Health Drugs Market Size
8.3 France Women’s Health Drugs Market Size
8.4 UK Women’s Health Drugs Market Size
8.5 Russia Women’s Health Drugs Market Size
8.6 Italy Women’s Health Drugs Market Size
8.7 Australia Women’s Health Drugs Market Size
8.8 Benelux Women’s Health Drugs Market Size
8.9 Nordic Women’s Health Drugs Market Size

9 MENA

9.1 MENA Women’s Health Drugs Market Size by Country
9.2 Saudi Arabia Women’s Health Drugs Market Size
9.3 UAE Women’s Health Drugs Market Size
9.4 Turkey Women’s Health Drugs Market Size
9.5 South Africa Women’s Health Drugs Market Size
9.6 Egypt Women’s Health Drugs Market Size

10 MARKET DRIVERS, CHALLENGES AND TRENDS

10.1 Market Drivers and Impact
  10.1.1 Growing Demand from Key Regions
  10.1.2 Growing Demand from Key Applications and Potential Industries
10.2 Market Challenges and Impact
10.3 Market Trends

11 KEY PLAYERS ANALYSIS

11.1 Bayer AG
  11.1.1 Bayer AG Company Information
  11.1.2 Bayer AG Women’s Health Drugs Product Offered
  11.1.3 Bayer AG Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.1.4 Bayer AG Main Business Overview
  11.1.5 Bayer AG Latest Developments
11.2 Allergan
  11.2.1 Allergan Company Information
  11.2.2 Allergan Women’s Health Drugs Product Offered
  11.2.3 Allergan Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.2.4 Allergan Main Business Overview
  11.2.5 Allergan Latest Developments
11.3 Merck & Co
  11.3.1 Merck & Co Company Information
  11.3.2 Merck & Co Women’s Health Drugs Product Offered
  11.3.3 Merck & Co Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.3.4 Merck & Co Main Business Overview
  11.3.5 Merck & Co Latest Developments
11.4 Pfizer Inc
  11.4.1 Pfizer Inc Company Information
  11.4.2 Pfizer Inc Women’s Health Drugs Product Offered
  11.4.3 Pfizer Inc Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.4.4 Pfizer Inc Main Business Overview
  11.4.5 Pfizer Inc Latest Developments
11.5 Amgen
  11.5.1 Amgen Company Information
  11.5.2 Amgen Women’s Health Drugs Product Offered
  11.5.3 Amgen Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.5.4 Amgen Main Business Overview
  11.5.5 Amgen Latest Developments
11.6 Agile Therapeutics Inc
  11.6.1 Agile Therapeutics Inc Company Information
  11.6.2 Agile Therapeutics Inc Women’s Health Drugs Product Offered
  11.6.3 Agile Therapeutics Inc Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.6.4 Agile Therapeutics Inc Main Business Overview
  11.6.5 Agile Therapeutics Inc Latest Developments
11.7 Ferring Pharmaceuticals
  11.7.1 Ferring Pharmaceuticals Company Information
  11.7.2 Ferring Pharmaceuticals Women’s Health Drugs Product Offered
  11.7.3 Ferring Pharmaceuticals Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.7.4 Ferring Pharmaceuticals Main Business Overview
  11.7.5 Ferring Pharmaceuticals Latest Developments
11.8 Mylan N.V.
  11.8.1 Mylan N.V. Company Information
  11.8.2 Mylan N.V. Women’s Health Drugs Product Offered
  11.8.3 Mylan N.V. Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.8.4 Mylan N.V. Main Business Overview
  11.8.5 Mylan N.V. Latest Developments
11.9 Lupin (India)
  11.9.1 Lupin (India) Company Information
  11.9.2 Lupin (India) Women’s Health Drugs Product Offered
  11.9.3 Lupin (India) Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.9.4 Lupin (India) Main Business Overview
  11.9.5 Lupin (India) Latest Developments
11.10 Eli Lilly And Company
  11.10.1 Eli Lilly And Company Company Information
  11.10.2 Eli Lilly And Company Women’s Health Drugs Product Offered
  11.10.3 Eli Lilly And Company Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.10.4 Eli Lilly And Company Main Business Overview
  11.10.5 Eli Lilly And Company Latest Developments
11.11 Novartis AG
  11.11.1 Novartis AG Company Information
  11.11.2 Novartis AG Women’s Health Drugs Product Offered
  11.11.3 Novartis AG Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.11.4 Novartis AG Main Business Overview
  11.11.5 Novartis AG Latest Developments
11.12 Johnson & Johnson
  11.12.1 Johnson & Johnson Company Information
  11.12.2 Johnson & Johnson Women’s Health Drugs Product Offered
  11.12.3 Johnson & Johnson Women’s Health Drugs Revenue and YoY Growth, 2019-2021E
  11.12.4 Johnson & Johnson Main Business Overview
  11.12.5 Johnson & Johnson Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Women’s Health Drugs Market Size CAGR by Region 2020-2026 ($ Millions)
Table 2. Global Women’s Health Drugs Market Size by Regions, 2016-2026 ($ millions)
Table 3. Global Women’s Health Drugs Market Size Share by Regions, 2016-2026
Table 4. Global Women’s Health Drugs Revenue by Player, 2019-2021E ($ millions)
Table 5. Global Women’s Health Drugs Revenue Market Share by Player, 2019-2021E
Table 6. Global Key Women’s Health Drugs Players Rank in 2020, Based on the Revenue in Women’s Health Drugs
Table 7. Global Key Women’s Health Drugs Players Head office and Products Offered
Table 8. Women’s Health Drugs Concentration Ratio (CR3, CR5 and CR10), 2019-2021E
Table 9. New Products and Potential Entrants
Table 10. Mergers & Acquisitions, Expansion
Table 11. Major Players of EVISTA
Table 12. Major Players of XGEVA
Table 13. Major Players of Prolia
Table 14. Major Players of Mirena
Table 15. Major Players of Zometa
Table 16. Major Players of Reclast/Aclasta
Table 17. Major Players of Minastrin 24 Fe
Table 18. Major Players of Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Table 19. Global Women’s Health Drugs Market Size CAGR by Type ($ millions): 2016 VS 2021 VS 2026
Table 20. Global Women’s Health Drugs Market Size by Type, 2016-2026 ($ millions)
Table 21. Global Women’s Health Drugs Market Size Share by Type, 2016-2026
Table 22. Global EVISTA Market Size by Region, 2016-2026 ($ millions)
Table 23. Global EVISTA Market Size Share by Region, 2016-2026
Table 24. Global XGEVA Market Size by Region, 2016-2026 ($ millions)
Table 25. Global XGEVA Market Size Share by Region, 2016-2026
Table 26. Global Prolia Market Size by Region, 2016-2026 ($ millions)
Table 27. Global Prolia Market Size Share by Region, 2016-2026
Table 28. Global Mirena Market Size by Region, 2016-2026 ($ millions)
Table 29. Global Mirena Market Size Share by Region, 2016-2026
Table 30. Global Zometa Market Size by Region, 2016-2026 ($ millions)
Table 31. Global Zometa Market Size Share by Region, 2016-2026
Table 32. Global Reclast/Aclasta Market Size by Region, 2016-2026 ($ millions)
Table 33. Global Reclast/Aclasta Market Size Share by Region, 2016-2026
Table 34. Global Minastrin 24 Fe Market Size by Region, 2016-2026 ($ millions)
Table 35. Global Minastrin 24 Fe Market Size Share by Region, 2016-2026
Table 36. Global Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Market Size by Region, 2016-2026 ($ millions)
Table 37. Global Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Market Size Share by Region, 2016-2026
Table 38. Women’s Health Drugs Market Size CAGR by Application ($ millions): 2016 VS 2021 VS 2026
Table 39. Global Women’s Health Drugs Market Size Forecast by Application, 2016-2026 ($ millions)
Table 40. Global Women’s Health Drugs Market Size Share Forecast by Application, 2016-2026
Table 41. Hormonal Infertility Market Size by Region, 2016-2026 ($ millions)
Table 42. Hormonal Infertility Market Size Share by Region, 2016-2026
Table 43. Postmenopausal Osteoporosis Market Size by Region, 2016-2026 ($ millions)
Table 44. Postmenopausal Osteoporosis Market Size Share by Region, 2016-2026
Table 45. Endometriosis Market Size by Region, 2016-2026 ($ millions)
Table 46. Endometriosis Market Size Share by Region, 2016-2026
Table 47. Contraceptives Market Size by Region, 2016-2026 ($ millions)
Table 48. Contraceptives Market Size Share by Region, 2016-2026
Table 49. Menopause Market Size by Region, 2016-2026 ($ millions)
Table 50. Menopause Market Size Share by Region, 2016-2026
Table 51. Polycystic Ovary Syndrome Market Size by Region, 2016-2026 ($ millions)
Table 52. Polycystic Ovary Syndrome Market Size Share by Region, 2016-2026
Table 53. Other Applications Market Size by Region, 2016-2026 ($ millions)
Table 54. Other Applications Market Size Share by Region, 2016-2026
Table 55. Americas Women’s Health Drugs Market Size by Country, 2016-2021 ($ Millions)
Table 56. Americas Women’s Health Drugs Market Size Share by Country, 2016-2021
Table 57. APAC Women’s Health Drugs Market Size by Region, 2016-2021 ($ Millions)
Table 58. APAC Women’s Health Drugs Market Size Share by Region, 2016-2021
Table 59. Europe Women’s Health Drugs Market Size by Country, 2016-2021 ($ Millions)
Table 60. Europe Women’s Health Drugs Market Size Share by Country, 2016-2021
Table 61. MENA Women’s Health Drugs Market Size by Country, 2016-2021 ($ Millions)
Table 62. MENA Women’s Health Drugs Market Size Share by Country, 2016-2021
Table 63. Key and Potential Regions of Women’s Health Drugs
Table 64. Key Application and Potential Industries of Women’s Health Drugs
Table 65. Key Challenges of Women’s Health Drugs
Table 66. Key Trends of Women’s Health Drugs
Table 67. Bayer AG Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 68. Bayer AG Women’s Health Drugs Product Offered
Table 69. Bayer AG Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 70. Bayer AG Main Business
Table 71. Bayer AG Latest Developments
Table 72. Allergan Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 73. Allergan Women’s Health Drugs Product Offered
Table 74. Allergan Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 75. Allergan Main Business
Table 76. Allergan Latest Developments
Table 77. Merck & Co Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 78. Merck & Co Women’s Health Drugs Product Offered
Table 79. Merck & Co Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 80. Merck & Co Main Business
Table 81. Merck & Co Latest Developments
Table 82. Pfizer Inc Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 83. Pfizer Inc Women’s Health Drugs Product Offered
Table 84. Pfizer Inc Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 85. Pfizer Inc Main Business
Table 86. Pfizer Inc Latest Developments
Table 87. Amgen Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 88. Amgen Women’s Health Drugs Product Offered
Table 89. Amgen Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 90. Amgen Main Business
Table 91. Amgen Latest Developments
Table 92. Agile Therapeutics Inc Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 93. Agile Therapeutics Inc Women’s Health Drugs Product Offered
Table 94. Agile Therapeutics Inc Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 95. Agile Therapeutics Inc Main Business
Table 96. Agile Therapeutics Inc Latest Developments
Table 97. Ferring Pharmaceuticals Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 98. Ferring Pharmaceuticals Women’s Health Drugs Product Offered
Table 99. Ferring Pharmaceuticals Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 100. Ferring Pharmaceuticals Main Business
Table 101. Ferring Pharmaceuticals Latest Developments
Table 102. Mylan N.V. Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 103. Mylan N.V. Women’s Health Drugs Product Offered
Table 104. Mylan N.V. Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 105. Mylan N.V. Main Business
Table 106. Mylan N.V. Latest Developments
Table 107. Lupin (India) Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 108. Lupin (India) Women’s Health Drugs Product Offered
Table 109. Lupin (India) Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 110. Lupin (India) Main Business
Table 111. Lupin (India) Latest Developments
Table 112. Eli Lilly And Company Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 113. Eli Lilly And Company Women’s Health Drugs Product Offered
Table 114. Eli Lilly And Company Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 115. Eli Lilly And Company Main Business
Table 116. Eli Lilly And Company Latest Developments
Table 117. Novartis AG Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 118. Novartis AG Women’s Health Drugs Product Offered
Table 119. Novartis AG Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 120. Novartis AG Main Business
Table 121. Novartis AG Latest Developments
Table 122. Johnson & Johnson Details, Head Office, Women’s Health Drugs Area Served and Its Competitors
Table 123. Johnson & Johnson Women’s Health Drugs Product Offered
Table 124. Johnson & Johnson Women’s Health Drugs Revenue ($ million) and YoY Growth, 2019-2021E
Table 125. Johnson & Johnson Main Business
Table 126. Johnson & Johnson Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Women’s Health Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Women’s Health Drugs Market Size Growth Rate, 2016-2026 ($ millions)
Figure 6. Women’s Health Drugs Consumption by Region (2016 VS 2021 & 2026) ($ millions)
Figure 7. Global Women’s Health Drugs Market Size Share by Regions, 2016-2026
Figure 8. Americas Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 9. APAC Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 10. Europe Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 11. MENA Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 12. Global Women’s Health Drugs Revenue Market Share by Player in 2020
Figure 13. Global Women’s Health Drugs Market Size Share by Type in 2020
Figure 14. Women’s Health Drugs in Hormonal Infertility
Figure 15. Global Women’s Health Drugs Market Size YoY Growth: Hormonal Infertility, 2016-2026 ($ millions)
Figure 16. Women’s Health Drugs in Postmenopausal Osteoporosis
Figure 17. Global Women’s Health Drugs Market Size YoY Growth: Postmenopausal Osteoporosis, 2016-2026 ($ millions)
Figure 18. Women’s Health Drugs in Endometriosis
Figure 19. Global Women’s Health Drugs Market Size YoY Growth: Endometriosis, 2016-2026 ($ millions)
Figure 20. Women’s Health Drugs in Contraceptives
Figure 21. Global Women’s Health Drugs Market Size YoY Growth: Contraceptives, 2016-2026 ($ millions)
Figure 22. Women’s Health Drugs in Menopause
Figure 23. Global Women’s Health Drugs Market Size YoY Growth: Menopause, 2016-2026 ($ millions)
Figure 24. Women’s Health Drugs in Polycystic Ovary Syndrome
Figure 25. Global Women’s Health Drugs Market Size YoY Growth: Polycystic Ovary Syndrome, 2016-2026 ($ millions)
Figure 26. Women’s Health Drugs in Other Applications
Figure 27. Global Women’s Health Drugs Market Size YoY Growth: Other Applications, 2016-2026 ($ millions)
Figure 28. Americas Women’s Health Drugs Value Market Share by Country in 2020
Figure 29. Women’s Health Drugs Market Size in United States, 2016-2026 ($ millions)
Figure 30. Canada Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 31. Mexico Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 32. Brazil Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 33. China Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 34. Japan Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 35. Korea Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 36. Taiwan Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 37. India Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 38. Australia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 39. Indonesia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 40. Thailand Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 41. Malaysia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 42. Philippines Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 43. Vietnam Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 44. Germany Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 45. France Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 46. UK Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 47. Russia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 48. Italy Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 49. Australia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 50. Benelux Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 51. Nordic Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 52. Saudi Arabia Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 53. UAE Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 54. Turkey Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 55. South Africa Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)
Figure 56. Egypt Women’s Health Drugs Market Size YoY Growth, 2016-2026 ($ millions)